Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 887 of 5804
-
Five minutes a day to stronger legs? a trial puts brief daily training to the test in older adults
Disease control Recruiting nowIn this study, we will randomly assign 360 older adults to 12 months of 5 minutes per day of functional resistance training or to a delayed treatment control condition, and measure the impact of the training on measures of lower extremity performance and walking ability.
Phase: PHASE2, PHASE3 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Coil treatment showdown: one side or both for brain bleed?
Disease control Recruiting nowThis is a pragmatic, prospective, multicenter, randomized controlled trial with intention to treat analysis. In which subjects will receive either unilateral or bilateral middle meningeal artery (MMA) embolization using coils for the treatment of unilateral chronic subdural hemat…
Phase: NA • Sponsor: Lahey Clinic • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Lying on stomach longer may save more lives in severe lung failure
Disease control Recruiting nowProne position (placing the patient on his abdomen) has been shown to be an effective intervention to decrease mortality in adults connected to mechanical ventilation for moderate to severe Acute Respiratory Distress Syndrome (ARDS). Patients may require one or more sessions of p…
Phase: NA • Sponsor: Pontificia Universidad Catolica de Chile • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Iron showdown: IV vs. pills for heart failure fatigue
Disease control TerminatedThe goal of this clinical trial is to learn which iron treatment works better for adults with congestive heart failure and low iron levels: intravenous (IV) iron given through a vein or oral (PO) iron taken by mouth. Participants must have heart failure with reduced ejection frac…
Phase: PHASE4 • Sponsor: Syed Hamza Mufarrih • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New shot may lower heart risk in patients whose medications block statins
Disease control Recruiting nowDrug-drug interactions often limit statin optimization in a population of patients prescribed cytochrome P3A4 inhibitors, which include immunosuppressive agents, protease inhibitors, and antifungals. These patients frequently have autoimmune conditions or rheumatologic disorders …
Phase: PHASE4 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Brain zaps on a schedule: new trial tests if less frequent rTMS can stop depression relapse
Disease control Recruiting nowRepetitive transcranial magnetic stimulation (rTMS) has emerged as a promising intervention for treatment-resistant depression (TRD), yet substantial uncertainties persist regarding its efficacy as a maintenance treatment. This prospective study seeks to investigate the efficacy …
Phase: NA • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Virtual reality and brain zaps aim to restore arm movement in stroke survivors
Symptom relief Recruiting nowThe investigators hypothesize that a myoelectric (EMG) controlled virtual reality (VR) interface allows for effective upper limb motor recovery of stroke patients. EMG control offers the possibility to alter visual feedback according to the recorded muscle activity in real-time. …
Phase: NA • Sponsor: I.R.C.C.S. Fondazione Santa Lucia • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
War-Torn ukraine tests At-Home HPV kits to fight cervical cancer
Knowledge-focused Recruiting nowIn 2020, a cervical screening center was established in Zaporizhzhia (Ukraine), initiating a pilot project to evaluate the prevalence of HPV among women in Eastern Ukraine. The findings were intended to lay the groundwork for the Ukrainian Ministry of Health in establishing a str…
Phase: NA • Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Radioactive tracers aim to spot Parkinson's in the brain
Diagnosis Recruiting nowTo evaluate the potential usefulness of 18F-FIAT-2, 18F-C05-05, 18F-SPAL-T-06 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various α-Syn-related disease patients.
Sponsor: Tianjin Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
New heart valve device shows promise in early trial
Disease control OngoingThe Siegel™ Transcatheter Aortic Valve (TAVR) early feasibility study objective is to assess the acute and long-term safety and feasibility of the Siegel TAVR device in adult subjects with symptomatic, severe native aortic stenosis eligible for the transcatheter aortic valve repl…
Phase: NA • Sponsor: MiRus • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New sleep aid aims to outperform standard insomnia treatment
Symptom relief CompletedThe main purpose of this study is to assess efficacy of YZJ-1139 for 28 days in adult subjects with insomnia disorder. Efficacy will be evaluated on objective and subjective sleep parameters.
Phase: PHASE3 • Sponsor: Shanghai Haiyan Pharmaceutical Technology Co., Ltd. • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Ear zap device could tame arthritis pain without drugs
Disease control Recruiting nowPurpose and aim The overall aim is to investigate efficacy and safety of a newly developed non-invasive auricular investigational device that electrically stimulates the auricular branch of the vagus nerve to activate the cholinergic anti-inflammatory mechanism to treat rheumato…
Phase: NA • Sponsor: taVNS AB • Aim: Disease control
Last updated Jun 26, 2026 16:34 UTC
-
Heart ultrasound gets a boost: new contrast agent aims for sharper images
Diagnosis OngoingThis is a Phase 3, prospective, open-label, multicenter study to assess the efficacy of NH002-enhanced echocardiography in subjects with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the left ventricular endocardial border delineation compared …
Phase: PHASE3 • Sponsor: Trust Bio-sonics, Inc. • Aim: Diagnosis
Last updated Jul 11, 2026 00:00 UTC
-
Custom-Made genetic drug targets rare brain disorder in one patient
Disease control OngoingThis research project entails delivery of a personalized antisense oligonucleotide (ASO) drug designed for a single participant with Autosomal Dominant Leukodystrophy (ADLD) due to LMNB1 mutation
Phase: PHASE1, PHASE2 • Sponsor: n-Lorem Foundation • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New hope for kids with arthritis: experimental drug enters final testing phase
Disease control Recruiting nowThe purpose of this study is to evaluate the drug levels, efficacy, and safety of Deucravacitinib (BMS-986165) in pediatric participants with juvenile psoriatic arthritis.
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New pill could help men keep their hair
Disease control OngoingThis study will evaluate the safety and efficacy of VDPHL01 in male subjects with Androgenetic Alopecia (AGA). AGA (or male pattern baldness) is a genetic disorder caused by an excessive (too much) hair follicle response to androgens (hormone) that causes hair loss. VDPHL01 8.5 …
Phase: PHASE3 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Sound waves to lift mood? new study tests ultrasound for depression
Symptom relief Recruiting nowThis study will evaluate a new form of non-invasive brain stimulation for individuals with depression. Personalized low-intensity transcranial focused ultrasound stimulation will be delivered using a range of stimulation parameters during psychological and physiological monitorin…
Phase: PHASE1, PHASE2 • Sponsor: Brian Mickey • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Smartphone therapy: could an app help men with HIV kick stimulants?
Disease control Recruiting nowThe purpose of this study is to find out if reSET, an FDA authorized mobile therapeutic, is effective in treating stimulant use disorder and helping keep HIV viral load suppression stable among men who have sex with men who are living with HIV and have a stimulant use disorder.
Phase: NA • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug milsaperidone aims to boost depression treatment
Symptom relief Recruiting nowThe purpose of this study is to determine the efficacy and safety of milsaperidone compared to placebo as adjunctive therapy in patients with Major Depressive Disorder
Phase: PHASE3 • Sponsor: Vanda Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
New hope for HER2+ breast cancer: switching drug combos after treatment fails
Disease control Recruiting nowThis study adopts a multicenter, natural selection, observational design, and plans to enroll patients with HER-2 positive advanced or metastatic breast cancer treated at approximately 20 research centers nationwide. Patients with de novo stage IV disease or those with recurrent …
Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC